Skip to main content
Clinical Trials/ACTRN12618001789257
ACTRN12618001789257
Completed
未知

PET/CT FIRST: A Prospective study of up-front PET/CT in guiding minimisation of number of diagnostic interventions of pulmonary nodules suspicious for lung cancer.

Royal Brisbane and Womens Hospital0 sites168 target enrollmentNovember 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
ung cancer
Sponsor
Royal Brisbane and Womens Hospital
Enrollment
168
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 1, 2018
End Date
April 25, 2023
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Brisbane and Womens Hospital

Eligibility Criteria

Inclusion Criteria

  • Referrals to Thoracic Medicine OPD or Inpatient Consults
  • Nodules 8\-30mm diameter, solid or semi\-solid
  • Brock risk calculator risk of malignancy of \>10%

Exclusion Criteria

  • Unsuitable for bronchoscopy
  • where nodules have morphology clearly suggestive of benign disease per BTS guidelines
  • peri\-fissural or subpleural nodules less than 10 mm diameter.
  • oGround Glass opacity nodules with less than 5 mm solid component – see reference
  • Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Diagnostic exam for renal cancer
RBR-6p8pkvqFundação Antônio Prudente - AC Camargo Cancer Center
Recruiting
Not Applicable
Prospective Evaluation of the Use of PET-CT in HepatocarcinomaHepatocellular carcinomaC04.588.274.623
RBR-3vxgjsjFundação Antônio Prudente - AC Camargo Cancer Center
Recruiting
Not Applicable
PET scan for measuring response in lymphoma of braiHealth Condition 1: C859- Non-Hodgkin lymphoma, unspecified
CTRI/2021/05/033776Tata Memorial Centre Mumbai
Completed
Not Applicable
A pilot study of clinical usefulness of PET-CT and PET-MRI in cancer patients treated with medical tharapyCancer
JPRN-UMIN000017136Department of Surgery, Fukushima Medical University100
Active, not recruiting
Phase 1
uPAR PET/CT og FDG PET/CT til præoperativ stadieinddeling af patienter med nydiagnosticeret Gynækologisk Kræftgynecological cancers:Vulvar cancerendometrial cancer (uterine cancer)cervical cancerovarian cancerMedDRA version: 20.0Level: LLTClassification code 10007107Term: Cancer of ovarySystem Organ Class: 100000021045MedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000020935MedDRA version: 20.0Level: LLTClassification code 10047743Term: Vulval cancer NOSSystem Organ Class: 100000021101MedDRA version: 20.0Level: LLTClassification code 10007063Term: Cancer of endometriumSystem Organ Class: 100000021008MedDRA version: 20.0Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000020977Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
EUCTR2016-004638-99-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET350